Bachmann, Friederike;Schreder, Martin;Engelhardt, Monika;Langer, Christian;Wolleschak, Denise;Mügge, Lars Olof;Dürk, Heinz;Schäfer-Eckart, Kerstin;Blau, Igor Wolfgang;Gramatzki, Martin;Liebisch, Peter;Grube, Matthias;V Metzler, Ivana;Bassermann, Florian;Metzner, Bernd;Röllig, Christoph;Hertenstein, Bernd;Khandanpour, Cyrus;Dechow, Tobias;Hebart, Holger;Jung, Wolfram;Theurich, Sebastian;Maschmeyer, Georg;Salwender, Hans;Hess, Georg;Bittrich, Max;Rasche, Leo;Brioli, Annamaria;Eckardt, Kai-Uwe;Straka, Christian;Held, Swantje;Einsele, Hermann;Knop, Stefan
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM.
Cancers (Basel)
2021
13
6

Kopp, C.;Lorenzen, S.;Gaiser, T.;Thuss-Patience, P. C.;Schenk, M.;Lindig, U.;Kretzschmar, A.;Heuer, V.;Goekkurt, E.;Haag, G. M.;Knorrenschild, J. Riera;Bolling, C.;Hofheinz, R. D.;Siebenhuener, A. R.;Irahara, N.;Waberer, L.;Pauligk, C.;Gotze, T. O.;Homann, N.;Al-Batran, S-E.
Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK
Ann Oncol
2021
32 Suppl 5
S1069-S1070

Bankstahl, U. S.;Al-Batran, S-E.;Piso, P.;Lorenzen, S.;Ostrzyzek, M.;Pauligk, C.;Habibzade, T.;Schenk, M.;Schlenska-Lange, A.;Reim, D.;Bechstein, W. O.;Koenigsrainer, A.;Moenig, S. P.;Rau, B.;Schwarzbach, M.;Goetze, T. O.
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma: The phase III "PREVENT" trial of the AIO/CAOGI/ACO
Ann Oncol
2021
32 Suppl 5
S1075-S1075

Hartmann, L.;Hecker, J. S.;Rothenberg-Thurley, M.;Riviere, J.;Ksienzyk, B.;Buck, M. C.;van der Garde, M.;Fischer, L.;Winter, S.;Rauner, M.;Tsourdi, E.;Sockel, K.;Schneider, M.;Kubasch, A. S.;Nolde, M.;Hausmann, D.;Luetzner, J.;Roth, A.;Bassermann, F.;Spiekermann, K.;Hofbauer, L. C.;Platzbecker, U.;Goetze, K. S.;Metzeler, K. H.
Mutational profiling of clonal hematopoiesis, MDS and sAML depicts diversities of clonal progression
Oncology Research and Treatment
2021
44 Suppl 2
126-126

Orberg, Erik Thiele;Goettert, Sascha;Hiergeist, Andreas;Meedt, Elisabeth;Kleigrewe, Karin;Herr, Wolfgang;Bassermann, Florian;Gessner, Andre;Holler, Ernst;Heidegger, Simon;Poeck, Hendrik
Microbial-Derived Metabolites Induce Epithelial Recovery Via the Sting Pathway in Mice and Men and Protect from Graft-Versus-Host Disease
Blood
2021
138 Suppl 1

Rautenberg, Christina;Stoelzel, Friedrich;Roellig, Christoph;Stelljes, Matthias;Gaidzik, Verena;Lauseker, Michael;Kriege, Oliver;Verbee, Mareike;Unglaub, Julia Marie;Thol, Felicitas;Krause, Stefan W.;Haenel, Mathias;Neuerburg, Charlotte;Vucinic, Vladan;Jehn, Christian-Friedrich;Severmann, Julia;Wass, Maxi;Fransecky, Lars;Chemnitz, Jens;Holtick, Udo;Schaefer-Eckart, Kerstin;Schroeder, Josephine;Kraus, Sabrina;Krueger, William;Kaiser, Ulrich;Scholl, Sebastian;Koch, Kathrin;Henning, Lea;Kobbe, Guido;Haas, Rainer;Alakel, Nael;Roehnert, Maximilian-Alexander;Sockel, Katja;Hanoun, Maher;Platzbecker, Uwe;Holderried, Tobias A. W.;Morgner, Anke;Heuser, Michael;Sauer, Tim;Goetze, Katharina S.;Wagner-Drouet, Eva;Doehne, Konstanze;Doehner, Hartmut;Schliemann, Christoph;Schetelig, Johannes;Bornhaeuser, Martin;Germing, Ulrich;Schroeder, Thomas;Middeke, Jan Moritz
Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia
Blood
2021
138 Suppl 1

Enssle, S.;Perl, M.;Nedelko, T.;Krieger, M.;Bassermann, F.;Poeck, H.;Heidegger, S.
Tumor cell-intrinsic Gasdermin E (GSDME) activation contributes to checkpoint inhibitor-mediated anticancer immunity
Oncology Research and Treatment
2021
44 Suppl 2
35-36

Braitsch, K.;Schmalbrock, L. K.;Jung, P.;Bumeder, I;Kiewe, P.;Westermann, J.;Bullinger, L.;Keller, U.;Bassermann, F.;Kroenke, J.;Goetze, K. S.;Rieger, K.
Venetoclax combined with HMA or LDAC for relapsed/refractory AML - real-world experience from two German academic centers
Oncology Research and Treatment
2021
44 Suppl 2
88-89

Orberg, Erik Thiele;Meedt, Elisabeth;Hiergeist, Andreas;Xue, Jinling;Ghimire, Sakhila;Tiefgraber, Melanie;Eismann, Tina;Goeldel, Sophia;Herhaus, Peter;Verbeek, Mareike;Bassermann, Florian;Quante, Michael;Weber, Daniela;Edinger, Matthias;Wolff, Daniel;Herr, Wolfgang;Deng, Li;Gessner, Andre;Holler, Ernst;Poeck, Hendrik
Longitudinal Analysis of Gut Bacteriome, Mycobiome, Virome and Metabolome in Allogeneic Stem Cell Transplantation Reveals Susceptibility for Acute Graft-Versus-Host Disease
Blood
2021
138 Suppl 1

Al-Batran, S-E.;Lorenzen, S.;Homann, N.;Thuss-Patience, P. C.;Schenk, M.;Lindig, U.;Kretzschmar, A.;Heuer, V.;Goekkurt, E.;Haag, G. M.;Knorrenschild, J. Riera;Bolling, C.;Hofheinz, R. D.;Siebenhuener, A. R.;Irahara, N.;Kopp, C.;Waberer, L.;Pauligk, C.;Gotze, T. O.;Gaiser, T.
Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK
Ann Oncol
2021
32 Suppl 5
S1069-S1069